UNICA IRIS Institutional Research Information System

LA NASA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 289.092
NA - Nord America 25.110
AS - Asia 11.855
SA - Sud America 1.910
Continente sconosciuto - Info sul continente non disponibili 1.099
AF - Africa 334
OC - Oceania 109
Totale 329.509
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 278.441
US - Stati Uniti d'America 24.624
SG - Singapore 4.413
CN - Cina 3.916
NL - Olanda 3.334
UA - Ucraina 1.854
SE - Svezia 1.514
BR - Brasile 1.461
VN - Vietnam 1.043
FI - Finlandia 912
DE - Germania 870
GB - Regno Unito 746
FR - Francia 654
HK - Hong Kong 480
IN - India 402
KR - Corea 320
CA - Canada 278
BD - Bangladesh 185
JP - Giappone 164
AR - Argentina 156
IQ - Iraq 142
MX - Messico 113
TR - Turchia 112
PL - Polonia 107
RU - Federazione Russa 102
ZA - Sudafrica 99
IE - Irlanda 97
AU - Australia 95
PK - Pakistan 89
AT - Austria 87
ES - Italia 75
EC - Ecuador 71
ID - Indonesia 69
IR - Iran 69
SA - Arabia Saudita 61
CO - Colombia 56
MY - Malesia 52
MA - Marocco 50
EG - Egitto 48
VE - Venezuela 47
UZ - Uzbekistan 44
PH - Filippine 43
BE - Belgio 39
CL - Cile 35
CZ - Repubblica Ceca 33
RO - Romania 31
CH - Svizzera 30
LT - Lituania 28
IL - Israele 27
JM - Giamaica 26
JO - Giordania 25
PY - Paraguay 25
AE - Emirati Arabi Uniti 23
ET - Etiopia 23
DK - Danimarca 22
TH - Thailandia 22
KE - Kenya 20
KZ - Kazakistan 20
PE - Perù 20
TW - Taiwan 18
NP - Nepal 17
TN - Tunisia 17
UY - Uruguay 17
AZ - Azerbaigian 15
PT - Portogallo 15
OM - Oman 14
CR - Costa Rica 13
DZ - Algeria 13
HU - Ungheria 13
MU - Mauritius 13
NZ - Nuova Zelanda 12
BO - Bolivia 11
PS - Palestinian Territory 11
DO - Repubblica Dominicana 10
IS - Islanda 10
LB - Libano 10
GE - Georgia 9
SK - Slovacchia (Repubblica Slovacca) 9
SY - Repubblica araba siriana 9
EU - Europa 8
GR - Grecia 8
PA - Panama 8
SD - Sudan 8
AL - Albania 7
BG - Bulgaria 7
BY - Bielorussia 7
NO - Norvegia 7
TZ - Tanzania 7
GY - Guiana 6
HN - Honduras 6
JE - Jersey 6
NG - Nigeria 6
PR - Porto Rico 6
RS - Serbia 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AO - Angola 5
CY - Cipro 5
NI - Nicaragua 5
QA - Qatar 5
Totale 328.335
Salva come PNG Salva come JPEG
Città #
Cagliari 268.369
Uta 7.753
Amsterdam 3.198
Ashburn 2.157
Singapore 2.131
Fairfield 1.950
Woodbridge 1.624
San Jose 1.484
Chandler 1.472
Boardman 1.269
Dallas 1.170
Houston 1.075
Ann Arbor 1.016
Jacksonville 955
Wilmington 857
Nyköping 847
Seattle 766
Beijing 722
Cambridge 668
Helsinki 591
Council Bluffs 559
New York 541
Los Angeles 531
Hong Kong 407
Hefei 406
Lauterbourg 328
Nanjing 316
Boston 308
Santa Clara 305
Ho Chi Minh City 303
The Dalles 266
Seoul 246
Milan 225
Dearborn 211
Hanoi 204
Munich 198
Shanghai 186
Buffalo 183
Rome 166
Dong Ket 150
San Diego 143
São Paulo 135
Columbus 112
Orem 108
Shenyang 103
Guangzhou 101
Toronto 92
Hebei 90
Changsha 89
Tokyo 89
Nanchang 83
Tianjin 82
Frankfurt am Main 81
Redondo Beach 81
Atlanta 80
Verona 80
Chicago 78
London 77
Redwood City 73
Rio de Janeiro 70
Warsaw 70
Nuremberg 69
Jiaxing 65
Washington 65
Orange 61
Brooklyn 60
Dublin 60
Baghdad 59
Menlo Park 59
Montreal 56
Pune 56
Denver 55
Phoenix 53
Mountain View 51
Vienna 51
Norwalk 50
Sassari 49
Chennai 48
Da Nang 45
San Francisco 42
Stockholm 40
Tashkent 40
Jinan 38
Mumbai 38
Sydney 38
Johannesburg 37
Brussels 36
Incheon 36
Haiphong 34
Manchester 34
Ningbo 32
Wuhan 32
New Delhi 29
Ankara 28
Auburn Hills 28
Istanbul 28
Turku 28
Brasília 27
Redmond 27
Zhengzhou 27
Totale 309.741
Salva come PNG Salva come JPEG
Nome #
Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis 4.579
HLA-G expression and role in advanced-stage classical Hodgkin lymphoma 3.587
The impact of NOD2/CARD15 SNPs on the severe gastrointestinal GVHD following allogeneic Stem Cell Transplantation in Sardinia population 3.461
Comparison Between an Artificial Neural Network and Logistic Regression in Predicting Long Term Kidney Transplantation Outcome 3.439
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.415
Absence of activating killer immunoglobulin-like receptor genes combined with hepatitis C viral genotype is predictive of hepatocellular carcinoma 3.371
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients 3.349
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.325
What unrelated hematopoietic stem cell transplantation in thalassemia taught us about transplant immunogenetics 3.321
Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients 3.319
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia 3.239
Reassessing the approach to informed consent: The case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 3.062
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.921
Kir haplotype aa is a possible predictive marker of complete molecular response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia 2.833
Ruolo del trapianto allogenico nelle talassemie 2.795
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma 2.751
Absence of histological myopathy in chronic myeloid leukemia patients complaining of muscle spasms and myalgia during treatment with nilotinib 2.722
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart 2.612
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients 2.609
In vitro ovine articular chondrocyte proliferation: experiments and modelling 2.557
A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes 2.525
Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells 2.264
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia 2.258
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.256
Health related quality of life in patients with onco-hematological diseases 2.245
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 2.199
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 2.175
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 2.129
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention 2.121
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.118
Homozygosity for Killer Immunoglobin-like Receptor (KIR) Haplotype a Is Associated to Negative Interim Positron Emission Tomography (PET) and a Favourable Outcome in Hodgkin Lymphoma 2.062
Ethical issues of unrelated hematopoietic stem cell transplantation in adult thalassemia patients 2.000
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.977
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study 1.973
Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia 1.963
Ruxolitinib therapy and telomere length in myelofibrosis 1.961
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life 1.949
Experimental analysis and modeling of in vitro mesenchymal stem cells proliferation 1.925
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature 1.910
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice 1.880
Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis 1.841
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors 1.841
THE HLA-G 14-BP POLYMORPHISM IS AN INDEPENDENT GENETIC RISK MARKER OF LONG-TERM KIDNEY TRANSPLANTATION OUTCOME 1.817
The human leukocyte antigen-g 14-bp polymorphism is an independent genetic risk marker of long-term kidney transplantation outcome 1.763
null 1.759
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.759
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting 1.691
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 1.621
Acute basophilic leukemia with U2AF1 mutation 1.596
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.587
Systemic Mastocytosis with Associated Primary Myelofibrosis 1.581
Unrelated bone marrow transplantation in Thalassemia. The experience of the Italian Bone Marrow transplant Group (GITMO) 1.555
T cell tyrosine phosphorylation response to transient redox stress 1.555
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 1.542
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes 1.541
Erythroblast morphology in refractory anemia with ring sideroblasts and thrombocytosis 1.536
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 1.508
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.488
Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report 1.475
Successful and safe stem cell mobilization using plerixafor in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia 1.469
Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party 1.467
Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency 1.462
Essential thrombocytemia following immune thrombocytopenia with JAK2V617F mutation 1.454
Perls stain grade in bone marrow aspirate correlates with overall survival in low-risk myelodysplastic patients 1.451
Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors 1.444
null 1.419
Resolution of capillary leak syndrome by extracorporeal membrane oxygenation 1.415
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients 1.405
Improved outcomes With retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: Final results of the randomized Italian-German APL0406 trial 1.378
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation 1.368
The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study 1.367
Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm 1.343
Systemic mastocytosis with associated BCRABL1-negative atypical chronic myeloid leukemia 1.343
Immunological deregulation in classic hodgkin lymphoma 1.330
A simulated case of chronic myeloid leukemia: the growing risk of Munchausen’s Syndrome by internet 1.327
Rectal involvement in pre-early T acute lymphoblastic leukemia 1.310
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated donor hematopoietic stem cell transplantation in thalassemia patients 1.306
The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia 1.299
Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major 1.282
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.262
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression? 1.246
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia 1.233
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.233
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial 1.229
Could there be Haemodynamic Stress Effects on Pro-Inflammatory CD14+CD16+ Monocytes during Convective-Diffusive Treatments? A Prospective Randomized Controlled Trial 1.224
Immunohistochemical findings in the lungs of COVID-19 subjects: Evidence of surfactant dysregulation 1.220
The role of inhibitory KIR 2DL5 in the outcome of autologous hematopoietic stem cell transplantation for multiple myeloma 1.219
Expression of l1 cell adhesion molecule (l1cam) in extracellular vesicles in the human spinal cord during development 1.217
Multiple myeloma treatment in real-world clinical practice: Results of a prospective, multinational, noninterventional study 1.210
White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy 1.204
Stem cell transplantation for congenital dyserythropoietic anemia. An analysis from the European society for blood and marrow transplantation 1.199
The usefulness of artificial neural networks in predicting the outcome of hematopoietic stem cell transplantation: a crystal ball to foresee the future? 1.178
Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two ABVD cycles: Long-term results of the GITIL/FIL HD 0607 trial 1.174
Dasatinib first-line: multicentric Italian experience outside clinical trials 1.170
null 1.138
Comparison between an artificial neural network and logistic regression in predicting acute graft-versus-host disease following unrelated haematopoietic stem cell transplantation 1.136
null 1.128
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity 1.113
null 1.110
The human carotid atherosclerotic plaque: an observational review of histological scoring systems 1.109
Totale 188.804
Salva come PNG Salva come JPEG
Categoria #
all - tutte 480.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 480.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216.287 0 1.598 760 1.108 1.369 1.078 857 1.108 1.518 2.163 2.377 2.351
2022/202325.815 2.001 2.970 2.705 1.991 2.030 2.703 1.279 3.292 1.629 1.580 2.425 1.210
2023/202429.541 1.598 1.200 1.519 2.189 2.610 4.937 3.738 2.052 1.522 2.385 2.983 2.808
2024/202558.229 9.818 10.782 9.877 6.931 3.620 6.636 3.175 487 1.063 3.964 829 1.047
2025/202622.229 1.362 955 2.691 1.967 1.543 1.418 5.298 891 1.644 2.157 1.231 1.072
2026/20271.441 526 915 0 0 0 0 0 0 0 0 0 0
Totale 329.509